RBC Capital Markets is turning more optimistic on Edgewell Personal Care ahead of the company's fiscal fourth-quarter earnings, scheduled for November 12. In a research note, the bank said its recent checks with retailers suggest sales growth is improving, with price increases doing most of the heavy lifting while unit volumes remain soft.
Edgewell, the maker of brands like Schick razors, Playtex, and Banana Boat sunscreen, surprised investors last quarter with a drop in sales that management attributed to one-off issues. RBC now believes the company's guidance is achievable, pointing to cost and execution initiatives that are beginning to show up in results.
What the channel checks reveal
Channel checks are a common research tool used by analysts to gauge real-time trends by talking to retailers, distributors, and other industry contacts. RBC's checks suggest that Edgewell's sales growth is accelerating, but the composition of that growth matters. Higher prices are contributing to revenue, which can help protect gross margins even when fewer units are sold.
However, the split between pricing and volume is a key concern. If volumes are still falling, it could indicate that consumers are trading down to cheaper alternatives or that retailers are pushing back on prices and demanding more promotions. That would make the current pricing strength less sustainable over time.
RBC reiterated its outperform rating on Edgewell with a price target of $35, while the shares were last reported at $29.84. That implies roughly 17% upside from current levels, but the bank's confidence hinges on whether volume trends are stabilizing.
Why November 12 matters
The upcoming earnings report will be a critical test for Edgewell. Investors will be looking for evidence that the volume decline is easing, not just that pricing is holding up. If volumes are still weak, the market may question whether the company's growth is durable or just a temporary margin boost from higher prices.
For everyday investors, this story highlights the importance of looking beyond the headline revenue number. A company can post strong sales growth driven by price increases, but if customers are buying fewer products, that growth may not be sustainable. The same dynamic is playing out across many consumer goods companies as they navigate inflation and shifting shopper behavior.
Edgewell's situation also reflects broader trends in the personal care sector, where companies are balancing input cost pressures with consumer sensitivity to price hikes. The outcome of its earnings could offer clues about the health of consumer spending and the pricing power of branded goods.
What it means for investors
RBC's positive stance is a signal that some analysts see value in Edgewell's stock, but it's not a recommendation to buy. Investors should use the November 12 report to assess whether the company's turnaround is on track. Key metrics to watch include organic sales growth, gross margin, and any commentary on volume trends and promotional activity.
If Edgewell can show that volumes are stabilizing, it would support the case that the company's pricing strategy is working without alienating customers. On the other hand, if volumes continue to slide, the stock could face pressure even if the headline numbers look decent.
For those who own Edgewell shares or are considering an investment, the earnings call will be the moment to gauge management's confidence and the sustainability of the recovery. As always, past performance is not a guarantee of future results, and it's wise to consider how this stock fits into a diversified portfolio.
